Category: Pharmaceuticals
Oceania Pharmaceuticals
-
Asia Pacific Medical Marijuana Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The Asia Pacific medical marijuana market is expected to grow from US$ 2,115.23 million in 2022 to US$ 6,203.80 million by 2028. It is ... Read More
-
Asia Pacific Track & Trace Solution Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Component (Hardware and Software), Enterprise Size (SMEs and Large Enterprise), Application (Serialization and Aggregation), and Industry (Pharmaceutical, Medical Devices, Consumer Goods, Food & Beverages, and Others)
... Medical Devices, Consumer Goods, Food & Beverages, and Others) The Asia Pacific track & trace solution market is expected to grow from US$ 1,899.66 million in 2023 to US$ 4,105.11 million by 2028. It is ... Read More
-
Asia Pacific Skull Clamp Market Forecast to 2028– COVID-19 Impact and Regional Analysis– by Product (Three-Pin Skull Clamp, Four-Pin Skull Clamp, and Two-Pin Skull Clamp), Application (Surgery and Medical Imaging), Material (Stainless Steel, Aluminum Alloy, Titanium, and Radiolucent), Accessories (Skull Pins, Headrest, and Others), and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)
... Titanium, and Radiolucent), Accessories (Skull Pins, Headrest, and Others), and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) The Asia Pacific Skull Clamp Market is expected to grow from US$ 228.59 million in 2022 ... Read More
-
Asia Pacific Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
... Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells) The Asia Pacific organoids market is expected to grow from US$ 419.14 million ... Read More
-
Asia Pacific Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Service Type (Lyophilization Cycle Development, Clinical Manufacturing, Commercial Manufacturing, and Freeze-Drying Analytical Services) and End User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others)
... & Biotechnology Companies, Research Institutes, and Others) The Asia Pacific lyophilization services for biopharmaceuticals market is expected to grow from US$ 334.18 million in 2023 to US$ 551.97 million by 2028. It is estimated to ... Read More
-
Asia Pacific Cardiac Microcatheter Market Forecast to 2028– COVID-19 Impact and Regional Analysis– by Indication (General Peripheral Vascular and Coronary) and End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers)
... market is expected to grow from US$ 80.47 million in 2023 to US$ 114.76 million by 2028. It is estimated to grow at a CAGR of 7.4% from 2023 to 2028. Surge in New Product ... Read More
-
Asia Pacific Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), Application (Neurologic Conditions, Pain Management, Nicotine Cessation, Cardiovascular Disorders, Hormonal Therapy, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
... Cardiovascular Disorders, Hormonal Therapy, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) The Asia Pacific transdermal medical patch market is expected to grow from US$ 2,126.31 million in 2023 to US$ ... Read More
-
Asia-pacific Botulinum Toxin Market 2023-2030
... China, Japan, Australia & New Zealand, South Korea, ASEAN countries, and Rest of Asia-Pacific are included in the region’s report. The growing prevalence of migraine in India is expected to elevate the demand for novel ... Read More
-
Asia Pacific Pharmacy Automation Market by Product Type (Dispensing, Storage - Robotic, Carousel, Cabinet), Packaging & Labelling, Table top, Medication Compounding], End User (Inpatient, Outpatient, Hospital Retail, PBM, Mail-order) & Country - Global Forecast to 2028
... 2028 The global Asia Pacific pharmacy automation market is projected to reach USD 763 million by 2028 from USD 496 million in 2023, at a CAGR of 9.0% during the forecast period. The ability to ... Read More
-
Australia Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 776 million by 2028, growing at a CAGR of 2.46% during the forecast period (2023-2028). The COVID-19 pandemic positively impacted the Australia Diabetes Care Devices Market growth. Patients with diabetes, infected with ... Read More
-
Calcium Lactate Market, By Application (Food & Beverages, Cosmetics, Feed Additives, Pharmaceuticals and others) and Geography (Asia Pacific, Europe, North America and Rest of the World) Drivers, Opportunities, Trends, and Forecasts Up to 2028
... is an essential element of the body structure. Due to changes in preferences and dietary habits, people in today’s life suffer from calcium deficiency which is complimented by the intake of calcium supplements. There are ... Read More
-
Australia And New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion in 2023 to USD 1.27 billion by 2028, at a CAGR of 2.70% during the forecast period (2023-2028). Key Highlights A holistic study of the market studied has been carried out by incorporating various ... Read More
-
Australia Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 939.07 million by 2028, growing at a CAGR of 3.60% during the forecast period (2023-2028). The COVID-19 epidemic boosted the expansion of the Australia Diabetes Care Drugs Market. Diabetes patients infected with ... Read More
-
Asia-Pacific Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 20.99 billion by 2028, at a CAGR of 2.68% during the forecast period (2023-2028). The Asia-Pacific region has witnessed an astounding increase in the prevalence of diabetes in patients, in recent years. The increasing ... Read More
-
New Zealand Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 357.92 million by 2028, at a CAGR of 2.60% during the forecast period (2023-2028). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients and older adult ... Read More
-
Asia-Pacific Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 28.67 billion by 2028, at a CAGR of 3.10% during the forecast period (2023-2028). COVID-19 caused a gradual rise in demand for diabetes medications in the Asia-Pacific region. Patients with COVID-19 and pre-existing diabetes ... Read More
-
Australia Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 775.73 million by 2028, at a CAGR of 2.40% during the forecast period (2023-2028). During the COVID-19 pandemic, patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, ... Read More
-
New Zealand Insulin Drugs And Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... million in 2023 to USD 546.59 million by 2028, at a CAGR of 1.10% during the forecast period (2023-2028). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The largest risk was ... Read More
-
New Zealand Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 839.07 million by 2028, at a CAGR of 4% during the forecast period (2023-2028). Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and older adult patients ... Read More
-
New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 495.73 million by 2028, at a CAGR of 3.30% during the forecast period (2023-2028). An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If they get COVID-19, ... Read More
-
Intractable Focal Epilepsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Elevating Neurological Care for Intractable Focal Epilepsy The global intractable focal epilepsy treatment market is gaining significant traction as a critical field within neurology, focusing on tackling persistent focal seizures that resist conventional medications. This ... Read More
-
Compounded Bioidentical Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) Tailored Hormone Therapies Gain Momentum The global compounded bioidentical hormone therapy market is rapidly advancing, offering tailored hormone treatments with a multitude of applications. These therapies, utilizing bioidentical hormones, are anticipated to bring forth ... Read More
-
Australia Ultrasound Devices Market Assessment, By Product Type [Diagnostic Ultrasound Systems, Therapeutic Ultrasound], By Portability [Trolley/Cart-Based, Compact/Handheld], By Display [Coloured, Black and White], By End-user [Hospitals, Diagnostic centre, Ambulatory Care Centres, Surgical Centres, Research and Academic Institutes, Others], By Application [Radiology, Cardiology, Obstetrics & Gynaecology, Gastroenterology, Urology, Others], By Distribution Channel [Online, Offline-Distributor, Manufacturer, Others], By Region, Opportunities, and Forecast, 2016-2030F
... Academic Institutes, Others], By Application [Radiology, Cardiology, Obstetrics & Gynaecology, Gastroenterology, Urology, Others], By Distribution Channel [Online, Offline-Distributor, Manufacturer, Others], By Region, Opportunities, and Forecast, 2016-2030F Australia Ultrasound Devices Market size was valued at USD ... Read More
-
Australia Medical Lasers Market Assessment, By Product Type [Solid State Laser Systems, Gas Laser Systems, Dye Laser Systems, Semiconductor Laser Systems, Diode Laser Systems] By Application [Ophthalmology, Dermatology/Aesthetics, Gynecology, Dentistry, Urology, Cardiovascular, Other Applications], By End-user [Surgical, Cosmetic, Dental], By Region, Opportunities and Forecast, 2016-2030F
... End-user [Surgical, Cosmetic, Dental], By Region, Opportunities and Forecast, 2016-2030F Australia Medical Lasers Market was valued at USD 627.29 million in 2022 and is expected to reach USD 1093.21 billion in 2030 with a CAGR ... Read More
-
Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics (2nd Edition), 2021-2030: Distribution by Type of Protein degrader (degronimids, PROTACs, SARDs / SERDs, and specific BET and DUB inhibitors and other inhibitors), Therapeutic Area (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World)
... (Neurological Disorders, Oncological Disorders, and Other Therapeutic Areas), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest ... Read More
Research Assistance
